A novel polymorphism of the human CD40 receptor with enhanced function

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• CD40 signaling is essential for immune responses against pathogens.
• The cytoplasmic domain of CD40 is highly conserved across species.
• A novel single nucleotide polymorphism (SNP) at position 227 (P227A) was identified in the CD40 cytoplasmic domain.

Purpose of the Study:

• To investigate the functional consequences of the novel CD40 P227A genetic variant.
• To determine the impact of this variant on immune cell signaling and cytokine production.

Main Methods:

• Functional studies using B-cell lines stably expressing human (h) CD40-P227A.
• Analysis of signaling pathways including c-Jun phosphorylation.
• Measurement of cytokine (IL-6, TNF-alpha) and immunoglobulin (Ig) production.
• Assessment of cooperation between CD40-P227A, B-cell receptor (BCR), and Toll-like receptor 9 (TLR9) signaling.

Main Results:

• Signaling via hCD40-P227A demonstrated increased c-Jun phosphorylation compared to wild-type hCD40.
• Enhanced secretion of pro-inflammatory cytokines IL-6 and TNF-alpha was observed with the P227A variant.
• Increased Ig production was noted with the hCD40-P227A variant.
• Cooperation between hCD40-P227A and BCR/TLR9 signaling led to elevated and synergistic IL-6 and Ig production.

Conclusions:

• The CD40 P227A variant represents a gain-of-function genetic alteration.
• This variant enhances immune signaling, cytokine production, and antibody generation.
• The findings highlight a novel genetic factor influencing human immune responses, particularly in populations with Mexican and South American descent.